聯得裝備(300545.SZ)控股股東聶泉質押展期1300萬股
格隆匯11月18日丨聯得裝備(300545.SZ)公佈,公司於近日接到公司控股股東聶泉的通知,獲悉聶泉將其持有的公司部分股份辦理了質押到期後延期購回業務,質押展期1300萬股,佔其所持股份比例14.08%,佔公司總股本比例9.02%。
截止至公告日,聶泉持有公司股票9231.4萬股,佔公司總股本的64.07%。此次質押延期股份為1300萬股,佔其持有的公司股份總額的14.08%,佔公司總股本的9.02%。聶泉累計質押股份2160萬股,佔其所持有的公司股份總額的23.40%,佔公司總股本的14.99%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.